IP Library Granted Patent US 8,298,211
Granted Patent B2
US 8,298,211 · App. 11/944,181 · Granted Oct 30, 2012

Push button pull back device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,298,211
App. No.
11/944,181
Granted
Oct 30, 2012
Kind
B2
Abstract

A site marker deployment device includes a housing defining a first portion, an outer cannula at least partially interposed within the first portion and having a proximal end and a distal end defined by an outer cannula aperture, an inner member at least partially interposed within the outer cannula, a first biasing portion, a second biasing portion, wherein the second biasing portion will selectively urge the outer cannula to move proximally relative to the inner member, and a site marker selectively disposed within the outer cannula adjacent the inner member, near the distal end of the outer cannula. The first biasing portion will selectively urge a site marker at least partially within the outer cannula.

Claims (34)

1. A site marker deployment device, comprising:

a housing defining a first portion;

an outer cannula at least partially interposed within the first portion and having a proximal end and a distal end defining an outer cannula aperture;

an inner member at least partially interposed within the outer cannula;

a first actuator configured to at least partially release a first biasing portion to thereby selectively retract a site marker from outside of the outer cannula to at least partially within the outer cannula, such that the site marker is retained at least partially within the outer cannula;

a second biasing portion configured to selectively urge the outer cannula to move proximally relative to the inner member and the site marker.

2. The device of claim 1 , wherein the first biasing portion is selectively coupled to the site marker via a retracting portion, and wherein the retracting portion, when moved in a generally proximal direction, will urge the site marker at least partially within the outer cannula.

3. The device of claim 2 , wherein the retracting portion, when moved further in the generally proximal direction, will disengage the site marker from the retracting portion.

4. The device of claim 1 , wherein the inner member includes a hollow cannula and the retracting portion is at least partially interposed within the inner member.

5. The device of claim 1 , wherein the target location is a lesion and the first biasing portion is a helical spring.

6. The device of claim 1 , further comprising the site marker, wherein the site marker includes a plurality of resilient elongated portions joined at a first end connection and a second end connection.

7. The device of claim 6 , wherein the site marker is configured to identify a biopsy location during at least one imaging procedure.

8. The device of claim 6 , wherein the site marker includes a generally elongated first filament member, the first filament member selectively configurable between a retracted configuration, wherein the site marker is selectively interposed within the inner cannula, and a deployed configuration, where the site marker cannot be interposed within the inner cannula, and wherein a portion of the site marker is elastically deformed when the site marker is interposed within the inner cannula.

9. The device of claim 1 , wherein the inner member is affixed to the housing such that the inner member does not move relative to the housing.

10. The device of claim 1 , further comprising a retracting portion at least partially selectively interposed within the outer cannula and selectively coupling the first biasing portion to the site marker such that the site marker will be urged at least partially within the outer cannula as energy is released by the first biasing member.

11. The device of claim 1 , further comprising a second actuator configured to at least partially release the second biasing portion.

12. A method of assembling a deployment device, comprising:

interposing a first member at least partially within an outer cannula;

interposing a retracting portion at least partially within an outer cannula;

coupling a retracting biasing portion to the retracting portion such that a first actuator configured to at least partially release the retracting biasing portion will cause movement of at least a portion of the retracting portion to selectively retract a site marker from outside of the outer cannula to at least partially inside of the outer cannula, such that the marker is retained at least partially within the outer cannula;

coupling a deployment biasing portion to the outer cannula for moving the outer cannula in a generally axial direction relative to the first member and the site marker; and

sterilizing the deployment device with a site marker not fully interposed within the outer cannula.

13. The method of claim 12 , further comprising the steps of sterilizing at least one of the deployment device and the site marker while at least a portion of the site marker is not interposed within the outer cannula.

14. A method of deploying a marker, comprising:

actuating a first actuator to at least partially release a first biasing portion of a site marker deployment device, wherein the first biasing portion is coupled to a retracting portion configured to retract a site marker within an outer cannula, to thereby selectively retract a site marker from outside of the outer cannula to at least partially inside of the outer cannula, such that the marker is retained at least partially within the outer cannula;

inserting at least a portion of the outer cannula within a desired site marker location; and

actuating a second actuator to at least partially release a second biasing portion of the site marker deployment device to retract the outer cannula such that a distal end of the outer cannula is moved toward a proximal end of the site marker deployment device relative to the site marker.

15. The method of claim 14 , wherein at least a portion of the retracting portion is selectively interposed within an inner member.

16. The method of claim 14 , wherein at least partially releasing the first biasing portion includes expanding a spring.

17. The method of claim 14 , further comprising sterilizing at least one of the deployment device and the site marker while at least a portion of the site marker is not interposed within the outer cannula.

18. The method of claim 14 , further comprising resiliently biasing at least a portion of the site marker as the site marker is urged within the outer cannula.

19. The method of claim 14 , wherein releasing the second biasing portion of the site marker deployment device urges the outer cannula to move relative to an inner member, wherein the inner member is interposed within the outer cannula.

20. The method of claim 14 , wherein actuating the first actuator of the site marker deployment device includes urging a sterilized site marker within the outer cannula.

21. The method of claim 14 , further comprising removing at least a portion of a biopsy device from an introducer, and wherein inserting at least a portion of the outer cannula within a desired site marker location includes inserting a distal end of the outer cannula within the introducer.

Assignments (11)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 12, 2010
From: ZIMMER, BRIAN
To: SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 025123/0692 →
TERMINATION OF PATENT SECURITY AGREEMENTS AND RELEASE OF SECURITY INTERESTS Recorded Aug 26, 2010
From: GOLDMAN SACHS CREDIT PARTNERS, L.P., AS COLLATERAL AGENT
To: HOLOGIC, INC.; R2 TECHNOLOGY, INC.; SUROS SURGICAL SYSTEMS, INC.; BIOLUCENT, LLC; DIRECT RADIOGRAPHY CORP.; CYTYC SURGICAL PRODUCTS II LIMITED PARTNERSHIP; CYTYC SURGICAL PRODUCTS LIMITED PARTNERSHIP; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS III, INC.; CYTYC PRENATAL PRODUCTS CORP.; THIRD WAVE TECHNOLOGIES, INC.
Reel/Frame 024892/0001 →
PATENT SECURITY AGREEMENT Recorded Jul 29, 2008
From: SUROS SURGICAL SYSTEMS, INC.
To: GOLDMAN SACHS CREDIT PARTNERS L.P., AS COLLATERAL AGENT
Reel/Frame 021311/0201 →
FIRST SUPPLEMENT TO PATENT SECURITY AGREEMENT Recorded May 7, 2008
From: SUROS SURGICAL SYSTEMS, INC.
To: GOLDMAN SACHS CREDIT PARTNERS L.P., AS COLLATERAL AGENT
Reel/Frame 020915/0549 →